PCG
ENZ

Private Capital Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Private Capital Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,250
Closed -$4K – 2208
2021
Q3 		$4K Buy
+1,250
New +$4.17K ﹤0.01% 1688

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Capital Group's ENZ Position: Q4 2021 in Review

Private Capital Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 1,250 shares — an estimated $4K sold.

Private Capital Group first reported a position in ENZ in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

  • Private Capital Group reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
  • Private Capital Group sold 1,250 Enzo Biochem, Inc. shares in Q4 2021, an estimated $4K.
  • Private Capital Group first reported a position in Enzo Biochem, Inc. in Q3 2021 and held it in 1 quarter.
  • Private Capital Group's Enzo Biochem, Inc. position peaked at $4K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on Private Capital Group's 13F filing for Q4 2021, filed 24 Jan 2022.